5th Annual Conference of the European Biosafety Association, 2002

Programme, Thursday, 21 March 2002

07.30 - 08.30	Registration
08.30 - 08.45	Welcome by EBSA President Dr. Frank Verbeeck, Bristol-Myers Squibb, Belgium
08.45 – 12.30	Session I: National and Global Disease Outbreaks Living with Bio-terrorism Chair: Prof. Dr. Franz X. Heinz, Institute of Virology, University of Vienna
08.45 – 09.30	The Control of Foot and Mouth Disease Virus Outbreak in the Netherlands: The Role of Hygiene Dr. A. Dekker, Head Laboratory Vesicular Diseases, ID Lelystad Institute for Animal Science and Health, The Netherlands
09.30 – 10.00	The Foot and Mouth Disease Epidemic in the UK 2001
10.00 - 10.30	Break / Exhibition
10.30 - 11.10	Bio-terrorism: Micro-organisms and Toxins as Weapons and Evaluation of Risk Dr. Robert Hawley Ph.D., CBSP, Chief, Safety and Radiation Protection, U.S. Army Medical Research Institute of Infectious Diseases, Fort Detrick, USA
11.10 - 11.40	Global Outbreak Alert and Response WHO's role in the fight against bio-terrrorism Dr. Cathy Roth, Global Alert and Response Team, Dept of Surveillance and Response, Communicable Disease Cluster, WHO Geneva
11.40 - 12.15	Bio-terrorism – The Role of Irradiation as a Counter-measure to Bio-terrorism Mr. Arnold Herer, Vice President of IBA Technology Group, Belgium
12.15 - 12.30	Panel Discussion
12.30 – 12.45	EBSA Honorary Membership
12.45 - 14.15	Lunch / Exhibition
14.15 – 17.20	Concurrent Session IIb Biological Materials, Main Auditorium
15.00 – 17.00	Concurrent Session IIa Transport of Biological Materials, Auditorium II
15.00 – 17.00	Concurrent Session IIa Transport of Biological Materials, Auditorium II Chair Person: Mr. David J. Cocker, MDCPartners Healthcare Consultants, Belgium
15.00 - 15.30	Future Directions: WHO Policy on Transport Biosafety Dr. Nicoletta Previsani, Department of Communicable Disease Surveillance and Response, WHO, Geneva
15.30 - 16.00	Break / Exhibition
16.00 - 16.30	CEN / ISO Standardisation Programme for Packaging of Infectious Substances Mr. Maxence Wittebolle, Belgian Packaging Institute, Brussels
16.30 - 17.00	Shipping: Training Responsibilities in Clinical Trials Dr. Frank Verbeeck, Bristol-Myers Squibb, Belgium
14.15 – 15.00	Concurrent Session IIb Pathogens Update, Main Auditorium Chair Person: Mr. Martin Jones, Pfizer, La Jolla, California, USA
14.15 – 15.00	HIV Emergence, Spread and Biosafety Aspects Dr. Remi Van Den Broeck Medical Director Medisearch Int., Belgium
15.00 - 15.30	The Polio Eradication Programme Dr. David Wood, Vaccines and Biologicals Department,  WHO, Geneva
15.30 - 16.00	Break / Exhibition
16.00 - 16.40	Smallpox: Eradication, Virus Stocks and Bio-terrorism Prof. Dr. Riccardo Wittek, Institute for Animal Biology, Lausanne, Switzerland
16.40 - 17.10	Horizon Scanning: Outlook for 2002-2003,Arbovirus and Viral Haemorrhagic Fever an Overview Dr. Hervé Zeller, National Reference Centre for Arbovirus and Viral Haemorrhagic Fever, Institute Pasteur Lyon, France
17.10 - 17.20	Discussion
17.30 - 18.30	EBSA Annual General Meeting EBSA Members Only, Main Auditorium
19.15	Evening Programme Vienna by night: EBSA Annual Reception and Dinner Sponsored by Novartis International, Basle, Switzerland Departure: 19.15 hrs, Lobby Kaiser Franz Joseph Deraghotel

© EBSA e.V. 2006 - 2010

[close window]